Biblio

Author Title Type [ Year(Desc)]
Filters: First Letter Of Title is W  [Clear All Filters]
2019
Isani, M.A., Gee, K., Schall, K., Schlieve, C.R., Fode, A., Fowler, K.L., and Grikscheit, T.C. (2019). Wnt signaling inhibition by monensin results in a period of Hippo pathway activation during intestinal adaptation in zebrafish.Am J Physiol Gastrointest Liver Physiol.
González, S., Oh, D., Baclagon, E.R., Zheng, J.J., and Deng, S.X. (2019). Wnt Signaling Is Required for the Maintenance of Human Limbal Stem/Progenitor Cells In Vitro.Invest Ophthalmol Vis Sci60, 107-112.
Ghosh, N., Hossain, U., Mandal, A., and Sil, P.C. (2019). The Wnt signaling pathway: a potential therapeutic target against cancer.Ann N Y Acad Sci.
Hou, X., Khan, M.Ruhul Amin, Turmaine, M., Thrasivoulou, C., Becker, D.L., and Ahmed, A. (2019). Wnt signaling regulates cytosolic translocation of Connexin 43.Am J Physiol Regul Integr Comp Physiol.
Sharon, N., Vanderhooft, J., Straubhaar, J., Mueller, J., Chawla, R., Zhou, Q., Engquist, E.N., Trapnell, C., Gifford, D.K., and Melton, D.A. (2019). Wnt Signaling Separates the Progenitor and Endocrine Compartments during Pancreas Development.Cell Rep27, 2281-2291.e5.
Mohamed, I.A., El-Badri, N., and Zaher, A. (2019). Wnt Signaling: The double-edged sword diminishing the potential of stem cell therapy in congenital heart disease.Life Sci116937.
Bu, L., Yang, Q., McMahon, L., Xiao, G.-Q., and Li, F. (2019). Wnt suppressor and stem cell regulator TCF7L1 is a sensitive immunohistochemical marker to differentiate testicular seminoma from non-seminomatous germ cell tumor.Exp Mol Pathol104293.
Moti, N., Yu, J., Boncompain, G., Perez, F., and Virshup, D.M. (2019). Wnt traffic from endoplasmic reticulum to filopodia.Plos One14, e0212711.
Wang, C., Han, X., Zhou, Z., Uyunbilig, B., Huang, X., Li, R., and Li, X. (2019). Wnt3a Activates the WNT-YAP/TAZ Pathway to Sustain CDX2 Expression in Bovine Trophoblast Stem Cells.Dna Cell Biol.
Ma, L., Wang, Y., Hui, Y., Du, Y., Chen, Z., Feng, H., Zhang, S., Li, N., Song, J., Fang, Y., et al. (2019). WNT/NOTCH Pathway Is Essential for the Maintenance and Expansion of Human MGE Progenitors.Stem Cell Reports.
F Rodriguez-Zaccaro, D., Valdovinos-Ayala, J., Percolla, M.I., Venturas, M.D., R Pratt, B., and Jacobsen, A.L. (2019). Wood structure and function change with maturity: Age of the vascular cambium is associated with xylem changes in current year growth.Plant Cell Environ.
Ojansivu, M., Rashad, A., Ahlinder, A.Elisabet, Massera, J., Mishra, A., Syverud, K., Finne-Wistrand, A., Miettinen, S., and Mustafa, K. (2019). Wood-based nanocellulose and bioactive glass modified gelatin-alginate bioinks for 3D bioprinting of bone cells.Biofabrication.
Pang, L., Sager, P., Yang, X., Shi, H., Sannajust, F., Brock, M., Wu, J.C., Abi-Gerges, N., Lyn-Cook, B., Berridge, B.R., et al. (2019). Workshop Report: FDA Workshop on Improving Cardiotoxicity Assessment With Human-Relevant Platforms.Circ Res125, 855-867.
Aljurf, M., Weisdorf, D., Hashmi, S.K., Nassar, A., Gluckman, E., Mohty, M., Rizzo, D., Pasquini, M., Hamadani, M., Saber, W., et al. (2019). Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (Part II): clinical, technical and socio-economic considerations.Biol Blood Marrow Transplant.
Aljurf, M., Weisdorf, D., Hashmi, S.K., Nassar, A., Gluckman, E., Mohty, M., Rizzo, D., Pasquini, M., Hamadani, M., Saber, W., et al. (2019). Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (Part II): Clinical, technical and socio-economic considerations.Hematol Oncol Stem Cell Ther.
Pasquini, M.C., Srivastava, A., Ahmed, S.Osman, Aljurf, M., Atsuta, Y., Doleysh, C., Galeano, S., Gluckman, E., Greinix, H., Hale, G., et al. (2019). Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I): Minimum requirements and beyond.Hematol Oncol Stem Cell Ther.
Rodrigues, M., Kosaric, N., Bonham, C.A., and Gurtner, G.C. (2019). Wound Healing: A Cellular Perspective.Physiol Rev99, 665-706.
Jones, R.Ellen, Foster, D.S., Hu, M.S., and Longaker, M.T. (2019). Wound healing and fibrosis: current stem cell therapies.Transfusion59, 884-892.
Cho, B.-S., Min, G.-J., Park, S.-S., Shin, S.-H., Yahng, S.-A., Jeon, Y.-W., Yoon, J.-H., Lee, S.-E., Eom, K.-S., Kim, Y.-J., et al. (2019). WT1 measurable residual disease assay in AML who underwent allogeneic hematopoietic stem cell transplantation; optimal time points, threshold, and candidates.Biol Blood Marrow Transplant.
Chen, Y.-A., Lu, C.-Y., Cheng, T.-Y., Pan, S.-H., Chen, H.-F., and Chang, N.-S. (2019). WW Domain-Containing Proteins YAP and TAZ in the Hippo Pathway as Key Regulators in Stemness Maintenance, Tissue Homeostasis, and Tumorigenesis.Front Oncol9, 60.

Pages